Is LEV or MRK a better dividend investment in 2026?

LEV currently yields 800.00% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: LEV offers higher current income.

What is the dividend yield difference between LEV and MRK?

LEV has a forward dividend yield of 800.00% ($2.00/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 796.75 percentage points.

Home › Compare › LEV vs MRK

LEV vs MRK: Dividend Comparison 2026

LEV yields 800.00% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 LEV wins by $2773896.43M in total portfolio value

INVESTMENT

TIME HORIZON10 years

LEV

● Live price

800.00%

Share price

$0.25

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2773896.46M

Annual income

$2,226,430,694,490.38

Full LEV calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — LEV vs MRK

📍 LEV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	LEV	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, LEV + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

LEV pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LEV

Annual income on $10K today (after 15% tax)

$68,000.00/yr

After 10yr DRIP, annual income (after tax)

$1,892,466,090,316.82/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, LEV beats the other by $1,892,466,089,509.08/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LEV + MRK for your $10,000?

LEV: 50%MRK: 50%

100% MRK50/50100% LEV

Portfolio after 10yr

$1386948.25M

Annual income

$1,113,215,347,720.34/yr

Blended yield

80.26%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

LEV

Analyst Ratings

Buy

Hold

Consensus: Hold

Price Target

$1.80

+620.0% upside vs current

Range: $1.00 — $5.00

Altman Z

-0.6

Piotroski

2/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LEV buys

MRK buys

No recent congressional trades found for LEV or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricLEVMRK

Forward yield	800.00% ✓	3.25%
Annual dividend / share	$2.00	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	0%	8.2% ✓
Portfolio after 10y	$2773896.46M ✓	$30.7K
Annual income after 10y	$2,226,430,694,490.38 ✓	$950.29
Total dividends collected	$2730603.49M ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Hold	Buy
Analyst price target	$1.80	$128.54 ✓

Year-by-year: LEV vs MRK ($10,000, DRIP)

Year	LEV Portfolio	LEV Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$90,700	$80,000.00	$11,192	$351.54	+$79.5K → LEV
2	$775,180	$678,130.84	$12,524	$392.70	+$762.7K → LEV
3	$6,246,019	$5,416,576.76	$14,015	$438.65	+$6.23M → LEV
4	$47,472,138	$40,788,897.61	$15,682	$489.96	+$47.46M → LEV
5	$340,525,323	$289,730,135.14	$17,547	$547.23	+$340.51M → LEV
6	$2,306,680,888	$1,942,318,792.24	$19,632	$611.16	+$2306.66M → LEV
7	$14,764,459,529	$12,296,310,979.28	$21,963	$682.53	+$14764.44M → LEV
8	$89,354,478,583	$73,556,506,887.09	$24,571	$762.18	+$89354.45M → LEV
9	$511,650,252,638	$416,040,960,553.41	$27,486	$851.08	+$511650.23M → LEV
10	$2,773,896,464,813	$2,226,430,694,490.38	$30,745	$950.29	+$2773896.43M → LEV

LEV vs MRK: Complete Analysis 2026

LEV — Stock

The Lion Electric Company designs, develops, manufactures, and distributes purpose-built all-electric medium and heavy-duty urban vehicles in North America. Its products include battery systems, chassis, bus bodies, and truck cabins. The company also distributes truck and bus parts, as well as accessories. The Lion Electric Company was incorporated in 2008 and is based in Saint-Jérôme, Canada.

Full LEV Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this LEV vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LEV vs SCHD LEV vs JEPI LEV vs O LEV vs KO LEV vs MAIN LEV vs JNJ LEV vs ABBV LEV vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.